Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Structure00:56

Viral Structure

65.9K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
65.9K
Vaccinations01:51

Vaccinations

45.6K
Overview
45.6K
Conjugated Proteins02:50

Conjugated Proteins

19.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
19.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

450
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
450

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colloidal Dispersions of Gramicidin D in Water: Preparation, Characterization, and Differential Cytotoxicity.

ACS omega·2025
Same author

The Role of Dendritic Cells in Adaptive Immune Response Induced by OVA/PDDA Nanoparticles.

Vaccines·2025
Same author

Emerging Cationic Nanovaccines.

Pharmaceutics·2024
Same author

Transient Coatings from Nanoparticles Achieving Broad-Spectrum and High Antimicrobial Performance.

Pharmaceuticals (Basel, Switzerland)·2023
Same author

Characterization and Differential Cytotoxicity of Gramicidin Nanoparticles Combined with Cationic Polymer or Lipid Bilayer.

Pharmaceutics·2022
Same author

Cationic and Biocompatible Polymer/Lipid Nanoparticles as Immunoadjuvants.

Pharmaceutics·2021
Same journal

Multiphysics Investigation on Thermal Characteristics of Internal Bio-Inspired V-Ribbed Cooling Channels for Outer Rotor PMSM.

Biomimetics (Basel, Switzerland)·2026
Same journal

Smart Logistics Model for Supply Chain Management via Brain-Inspired Geometric Deep Networks.

Biomimetics (Basel, Switzerland)·2026
Same journal

A Systematic Taxonomy of the Sunflower Optimization Algorithm: Variants, Hybridization Strategies, Applications, and Research Directions.

Biomimetics (Basel, Switzerland)·2026
Same journal

Toward a Compositional Theory of Trust in Embodied Intelligence: A QNLP Framework for Modeling Context, Interaction, and Trustworthiness.

Biomimetics (Basel, Switzerland)·2026
Same journal

Empirical Logic for Bio-Inspired Soft Computing: Illustrative Applications in Control Engineering and Cluster Analysis.

Biomimetics (Basel, Switzerland)·2026
Same journal

A Modified Multi-Strategy Dhole Optimization Algorithm and Its Engineering Applications.

Biomimetics (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Oct 5, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Supramolecular Nanostructures for Vaccines.

Ana Maria Carmona-Ribeiro1

  • 1Biocolloids Laboratory, Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Avenida Professor Lineu Prestes, 748, Butantan, São Paulo CEP 05508-000, SP, Brazil.

Biomimetics (Basel, Switzerland)
|January 25, 2022
PubMed
Summary
This summary is machine-generated.

Bionanotechnology is advancing vaccine development for diseases like cancer and infections. This study explores nanovaccines and nanoadjuvants, highlighting their potential in disease prevention and treatment.

Keywords:
adjuvants for humoral and cellular immune responsesbilayer disks and fragmentsbiocompatible polymerscationic lipids and polymershydrogelsliposomesnanogelsnanoparticlesniosomesvesicles

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.7K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

Related Experiment Videos

Last Updated: Oct 5, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.7K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

Area of Science:

  • Bionanotechnology
  • Immunology
  • Nanomedicine

Background:

  • The current era faces pandemics and significant diseases, necessitating novel preventive strategies.
  • Bionanotechnology offers promising solutions, particularly in vaccine development.
  • Nanovaccines are emerging as a key area for disease prevention and treatment.

Purpose of the Study:

  • To deepen the understanding of nanovaccines and their mechanisms of action.
  • To explore the role of nanovaccines in preventing or treating cancer, infectious diseases, and parasitic diseases.
  • To contextualize current research within the broader field of nanovaccines and nanoadjuvants.

Main Methods:

  • Review and contextualization of major nanoadjuvants and nanovaccines.
  • Analysis of the properties and mechanisms of nanovaccines.
  • Exploration of the relative importance of specific research within the field.

Main Results:

  • Nanovaccines show potential in preventing and treating a range of diseases.
  • Key properties for effective nanoadjuvants include nanosize, cationic character, and biocompatibility.
  • Efficacy can be achieved in a low dose-dependent manner.

Conclusions:

  • Nanovaccines represent a significant advancement in modern medicine.
  • The identified properties are crucial for developing next-generation nanoadjuvants.
  • Further research is warranted to fully harness the potential of nanovaccines.